Centogene AG. (1/3/18). "Press Release: Centogene to Present at the 36th Annual J.P. Morgan Healthcare Conference". Rostock.

	Region	San Francisco, CA
	Country	United States (USA)
	Organisation	Centogene AG
	Group	Centogene (Group)
	Organisation 2	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco
	Product 2	CentoMD® rare disease variant database
	Index term	Centogene–JPMorgan Chase: investor conference, 201801 supply service Centogene presents at JP Morgan Healthcare Conference 2018
	Person	Arnold, Lauren (MacDougall Biomedical Communications 201801)

CENTOGENE, the worldwide leader in diagnosing, profiling, tracking and elucidating rare diseases for patients, clinicians and pharmaceutical partners, today announced that it will make a formal presentation at the 36th Annual J.P. Morgan Healthcare Conference. The company will provide a corporate update on Thursday, January 11, 2018 at 11:00 am PT.

About CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical companies developing life-changing orphan drugs.

As one of the most diversified and largest genetic testing companies worldwide, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients and their families. www.centogene.com; www.centoMD.com

Contacts

MacDougall Biomedical Communications
Lauren Arnold, 781-235-3060
larnold@macbiocom.com

Record changed: 2023-06-05